Drug Safety in Developing Countries: Achievements and Challenges provides comprehensive information on drug safety issues in developing countries. Drug safety practice in developing countries varies substantially from country to country. This can lead to a rise in adverse reactions and a lack of reporting can exasperate the situation and lead to negative medical outcomes. This book documents the history and development of drug safety systems, pharmacovigilance centers and activities in developing countries, describing their current situation and achievements of drug safety practice. Further, using extensive case studies, the book addresses the challenges of drug safety in developing countries.
- Provides a single resource for educators, professionals, researchers, policymakers, organizations and other readers with comprehensive information and a guide on drug safety related issues
- Describes current achievements of drug safety practice in developing countries
- Addresses the challenges of drug safety in developing countries
- Provides recommendations, including practical ways to implement strategies and overcome challenges surrounding drug safety
1. Introduction: Why do we need a book on Drug Safety in developing countries?
Section 1: Drug safety related issues 2. Medications safety related terminology 3. Medications registration and marketing: Safety related issues 4. Pharmacovigilance 5. Adverse Drug Reactions 6. Medication errors 7. Self-medications 8. Antibiotics safety issues 9. Drug related problems (DRPs) 10. Counterfeit and substandard medications 11. Medications abuse and misuse 12. Storage and disposal of medications 13. Safety of medications in special populations 14. Herbal medicines safety issues 15. Medications safety resources and tools 16. Medications safety Pharmacoeconomics related issues 17. Evidence-Based Medication Safety Practice 18. Technology in Medications safety 19. Medications safety research issues 20. Quality Indicators for medications safety
Section 2: Drug Safety in Asia 21. Drug safety in Malaysia 22. Drug safety in Thailand 23. Drug safety in Indonesia 24. Drug safety in Pakistan 25. Drug safety in India 26. Drug safety in Nepal 27. Drug safety in Sri Lanka 28. Drug Safety in China
Section 3: Drug Safety in Middle East 29. Drug safety in Yemen 30. Drug safety in Saudi Arabia 31. Drug safety in UAE 32. Drug safety in Jordan 33. Drug safety in Lebanon 34. Drug safety in Palestine 35. Drug safety in Qatar
Section 4: Drug Safety in Africa 36. Drug safety in Sudan 37. Drug safety in Egypt 38. Drug safety in Nigeria 39. Drug safety in Mali 40. Drug safety in Burkina Faso
Section 5: Drug Safety in Latin America 41. Drug safety in Chile
Section 6: Comparisons and conclusions 42. Compare between the developing countries 43. Drug Safety in Developing Versus Developed countries
Dr. Yaser Mohammed Al-Worafi is a Professor of Clinical Pharmacy at College of Pharmacy, Ajman University, UAE & UST-Yemen. He graduated with a bachelor's degree in Pharmacy (BPharm) from Sana'a University, Yemen and obtained Master and PhD degree in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. He has more than 15 years' experience in education, practice and research in Yemen, Saudi Arabia, United Arab Emirates and Malaysia. He has held various academic and professional positions including: Head of pharmacy Practice department; Teaching & learning committee, Training committee and other committees. He has published over 40 peer-reviewed papers in international journals, book chapters and editing many books. He is a reviewer for eight recognized International peer-reviewed journals. Dr. Al-Worafi prepared and wrote the first draft of Master of Clinical pharmacy program and PharmD internship manual.